Published in PLoS Pathog on April 03, 2014
Whole genome comparisons suggest random distribution of Mycobacterium ulcerans genotypes in a Buruli ulcer endemic region of Ghana. PLoS Negl Trop Dis (2015) 1.51
Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol (2014) 1.44
INS-gene mutations: from genetics and beta cell biology to clinical disease. Mol Aspects Med (2014) 0.86
Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen. PLoS Negl Trop Dis (2014) 0.86
Mechanistic insights into the inhibition of Sec61-dependent co- and post-translational translocation by mycolactone. J Cell Sci (2016) 0.81
Mycolactone subverts immunity by selectively blocking the Sec61 translocon. J Exp Med (2016) 0.80
Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease. Cell Microbiol (2016) 0.79
Genetic Variation in Toll-Interacting Protein Is Associated With Leprosy Susceptibility and Cutaneous Expression of Interleukin 1 Receptor Antagonist. J Infect Dis (2015) 0.78
Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions. PLoS Pathog (2015) 0.78
Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis. J Biol Chem (2015) 0.78
Bacterial Toxins as Pathogen Weapons Against Phagocytes. Front Microbiol (2016) 0.77
Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation. PLoS Biol (2014) 0.76
Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells. EMBO J (2017) 0.76
Mycolactone reveals the substrate-driven complexity of Sec61-dependent transmembrane protein biogenesis. J Cell Sci (2017) 0.75
In vitro antibacterial activity and in vivo efficacy of hydrated clays on Mycobacterium ulcerans growth. BMC Complement Altern Med (2016) 0.75
Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease. Sci Rep (2015) 0.75
Genetic Variation in Autophagy-Related Genes Influences the Risk and Phenotype of Buruli Ulcer. PLoS Negl Trop Dis (2016) 0.75
Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons: Mechanisms underlying hypoalgesia in Buruli ulcer. Mol Pain (2016) 0.75
Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export. Proc Natl Acad Sci U S A (2017) 0.75
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. Toxins (Basel) (2017) 0.75
Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell (2011) 10.56
X-ray structure of a protein-conducting channel. Nature (2003) 9.20
Preparation of microsomal membranes for cotranslational protein translocation. Methods Enzymol (1983) 6.94
Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science (1999) 6.37
Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes. Nature (2007) 4.99
Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci U S A (2004) 3.52
Post-transcriptional control of cytokine production. Nat Immunol (2008) 3.30
A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun (2000) 3.27
Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites. RNA (1998) 3.00
Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol (2011) 2.75
P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J Immunol (2008) 2.72
WASP: a key immunological multitasker. Nat Rev Immunol (2010) 2.38
A substrate-specific inhibitor of protein translocation into the endoplasmic reticulum. Nature (2005) 2.21
The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function. J Immunol (1999) 2.03
The translocation, folding, assembly and redox-dependent degradation of secretory and membrane proteins in semi-permeabilized mammalian cells. Biochem J (1995) 1.98
Tail-anchored membrane protein insertion into the endoplasmic reticulum. Nat Rev Mol Cell Biol (2011) 1.95
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. Cell Microbiol (2005) 1.93
Partitioning and translation of mRNAs encoding soluble proteins on membrane-bound ribosomes. RNA (2003) 1.87
Immune response to infection with Mycobacterium ulcerans. Infect Immun (2001) 1.82
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat Rev Microbiol (2009) 1.77
Biogenesis of tail-anchored proteins: the beginning for the end? J Cell Sci (2009) 1.64
Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo. Cell Microbiol (2005) 1.61
Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology (Oxford) (2008) 1.59
Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice. Infect Immun (2005) 1.59
Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection. Clin Infect Dis (2011) 1.58
Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1. Nature (2005) 1.56
Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes. Genes Dev (2009) 1.56
Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone. J Exp Med (2007) 1.48
Endoplasmic reticulum (ER)-associated degradation of misfolded N-linked glycoproteins is suppressed upon inhibition of ER mannosidase I. J Biol Chem (2000) 1.44
The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system. J Biol Chem (2006) 1.44
Regulation of protein transport from the Golgi complex to the endoplasmic reticulum by CDC42 and N-WASP. Mol Biol Cell (2002) 1.42
Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin. PLoS Negl Trop Dis (2007) 1.40
Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection. Infect Immun (2007) 1.40
Apratoxin a reversibly inhibits the secretory pathway by preventing cotranslational translocation. Mol Pharmacol (2009) 1.28
Analysis of mRNA partitioning between the cytosol and endoplasmic reticulum compartments of mammalian cells. Methods Mol Biol (2008) 1.28
Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs. PLoS Negl Trop Dis (2008) 1.27
Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans. Clin Infect Dis (2003) 1.23
Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease. J Infect Dis (2009) 1.22
Mechanism of puromycin action: fate of ribosomes after release of nascent protein chains from polysomes. Proc Natl Acad Sci U S A (1973) 1.21
The ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97/VCP inhibitory group. PLoS One (2010) 1.21
Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events. J Immunol (2009) 1.20
Total synthesis of the mycolactones. Org Lett (2002) 1.15
Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum. J Cell Sci (2009) 1.15
Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism. J Immunol (2009) 1.15
Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans. Microb Pathog (2003) 1.13
Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression. Proc Natl Acad Sci U S A (2011) 1.07
Cell elasticity determines macrophage function. PLoS One (2012) 1.05
Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation. J Clin Invest (2013) 1.04
Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression. Infect Immun (2010) 1.00
Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease. PLoS Negl Trop Dis (2013) 0.98
Potential of rifamides to inhibit TNF-induced NF-kappaB activation. J Antimicrob Chemother (2002) 0.93
Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection. PLoS One (2012) 0.92
Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer. Biochem Soc Trans (2014) 0.89
kappa-casein-deficient mice fail to lactate. Proc Natl Acad Sci U S A (2006) 0.89
Inhibition of protein translocation at the endoplasmic reticulum promotes activation of the unfolded protein response. Biochem J (2012) 0.89
Chemical and pharmacological chaperones: application for recombinant protein production and protein folding diseases. Curr Med Chem (2011) 0.89
Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection. PLoS Negl Trop Dis (2012) 0.87
Efficient sorting of TNF-alpha to rodent mast cell granules is dependent on N-linked glycosylation. Eur J Immunol (2006) 0.83
Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease. PLoS Negl Trop Dis (2013) 0.81
Effect of rifampin on production of inflammatory mediators in HepG2 liver epithelial cells. Antimicrob Agents Chemother (2011) 0.79